Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
MRKR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $15.84M
- EPS (TTM)
- -$0.42
- Dividend yield
- None
- 52-week range
- 0.84 – 2.46
- Day range
- 0.95 – 1.04
- Volume / Avg
- 96.40K / 64.80K
- Beta
- —
- Shares outstanding
- 16.67M
52-week range
MRKR stock today
Marker Therapeutics (MRKR) closed at $0.95 on Oct 8, down 8.65% (-$0.09), versus the S&P 500's 0.47% decline. At this level, MRKR sits near the bottom of its 52-week range of $0.84 to $2.46: 61.4% below the high, set on Jan 8, 2026 and 13.1% above the low. MRKR is down 30.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 1.9%.
Marker Therapeutics has posted a net loss over the last twelve months (EPS of -$0.42), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Marker Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Marker Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NCELNewcelX Ltd. | 3.11 | +2.47% | $17.96M | vs MRKR |
| NEUPNeuphoria Therapeutics Inc. | 3.35 | -2.05% | $18.13M | vs MRKR |
| ACTUActuate Therapeutics Inc. | 0.679 | -6.24% | $16.31M | vs MRKR |
| RADXRadiopharm Theranostics Limited ADR | 1.11 | -3.48% | $16.20M | vs MRKR |
| RKTORocket One Inc. | 0.6461 | -3.57% | $16.09M | vs MRKR |
| PTNPalatin Technologies Inc. | 9.01 | -5.36% | $16.05M | vs MRKR |
| LPCNLipocine Inc. | 1.93 | -12.27% | $15.91M | vs MRKR |
| AEONAEON Biopharma Inc. Class A | 0.3145 | +1.04% | $15.69M | vs MRKR |
Indexes, lists and sector
Marker Therapeutics stock FAQ
What is Marker Therapeutics's stock price today?
MRKR last traded at $0.95 as of Oct 8, 4:00 PM EDT, down 8.65% on the day. Prices are delayed at least 15 minutes.
Does Marker Therapeutics pay a dividend?
No. Marker Therapeutics does not currently pay a regular cash dividend.
Has MRKR ever split its stock?
Yes. The most recent MRKR stock split was a 1-for-10 split on Jan 27, 2023, one of 5 splits on record.
What is the MRKR 52-week high?
The 52-week high for MRKR is $2.46 and the 52-week low is $0.84. The stock is currently 61.4% below its high.